Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00682851 · ClinicalTrials.gov registry record

A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test

A clinical trial of Bacterial Vaginosis and Urogenital Infection by Trichomonas Vaginalis, sponsored by University of Pittsburgh.

Completed
Registry status
519
Enrollment target
1
Study location

NCT00682851 is a study of Bacterial Vaginosis and Urogenital Infection by Trichomonas Vaginalis that has completed, run by University of Pittsburgh. The registered enrollment target is 519 participants, above the 304-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00682851, a study of Bacterial Vaginosis and Urogenital Infection by Trichomonas Vaginalis, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
519 participants
Enrollment target
1
Study location

Study Summary

This research is being done to see if two rapid bedside tests (OSOM Trichomonas Rapid Test and BVBlue Test) that give results in 10 minutes are as accurate as standard tests to diagnose common vaginal infections.

Interventions

  • DEVICE OSOM Trichomonas Rapid Test
  • DEVICE OSOM BVBlue Test

Study Locations (1)

Pennsylvania

  • Magee-Womens Hospital of UPMC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 519 participants
Start Date 2008-07
Est. Completion 2009-04

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00682851

The ClinicalTrials.gov registry entry for NCT00682851 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 519 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 304-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (71% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bacterial Vaginosis appearing as the primary indexed condition, and to 2 interventions - of which OSOM Trichomonas Rapid Test is the first listed.

NCT00682851 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00682851 about?

NCT00682851 is a clinical study titled "A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test". This research is being done to see if two rapid bedside tests (OSOM Trichomonas Rapid Test and BVBlue Test) that give results in 10 minutes are as accurate as standard tests to diagnose common vaginal infections.

What is the current status of trial NCT00682851?

This trial is currently completed. The enrollment target is 519 participants. The study started on 2008-07. Estimated completion is 2009-04.

What conditions does trial NCT00682851 study?

This clinical trial studies the following conditions: Bacterial Vaginosis, Urogenital Infection by Trichomonas Vaginalis.

What interventions are being tested in trial NCT00682851?

The interventions under investigation include: OSOM Trichomonas Rapid Test (DEVICE), OSOM BVBlue Test (DEVICE).

Who is sponsoring clinical trial NCT00682851?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00682851 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bacterial Vaginosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.